Effects of aspirin and propranolol alone and in combination on hemostatic determinants in the healthy cat

Insights

Aspirin at 75 mg daily significantly impacts feline platelet function, particularly collagen-induced aggregation. This suggests aspirin may help prevent thromboembolic disease in cats.

Area of Science:

  • Veterinary Pharmacology
  • Feline Medicine
  • Hemostasis

Background:

  • Thromboembolic disease is a significant concern in feline medicine.
  • Understanding the effects of common medications on hemostasis is crucial for safe and effective treatment.

Purpose of the Study:

  • To investigate the effects of aspirin and propranolol, alone and in combination, on hemostatic parameters in healthy cats.
  • To determine the potential of aspirin in preventing thromboembolic events in felines.

Main Methods:

  • Healthy cats received aspirin (75 mg orally) and propranolol (5 mg orally every 8 hours) individually and concurrently.
  • Hemostatic determinants including platelet count, fibrinogen, coagulation times (aPTT, PT, TT), and platelet aggregation were measured.

Main Results:

  • Aspirin alone significantly reduced platelet aggregation induced by acid soluble collagen.
  • Neither aspirin nor propranolol, alone or combined, significantly affected platelet numbers, fibrinogen, or standard coagulation times.
  • Propranolol did not alter platelet aggregation responses to various agonists.

Conclusions:

  • Aspirin, at a dosage of 75 mg every other day, significantly affects platelet function in cats.
  • This dosage of aspirin may be beneficial in preventing thromboembolic disease in feline patients.